The Application of Continuous Blood Glucose Monitoring in Optimizing the Management of Type 2 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

November 30, 2025

Conditions
Continuous Glucose MonitoringType 2 Diabetes (T2DM)
Interventions
DEVICE

Continuous blood glucose monitoring assisted blood glucose management

(1) individualized health education sessions conducted by endocrinology healthcare providers covering CGM concepts, usage methods, advantages, risks, and precautions, along with hands-on device demonstration and provision of written materials and user manuals; (2) development of an integrated CGM data management platform that connects with community healthcare information systems for real-time data transmission, storage, and analysis; (3) establishment of standardized CGM response protocols for healthcare providers, including glucose target setting, dietary and exercise recommendations, personalized medication adjustments based on glucose fluctuations, and management procedures for hypoglycemic and hyperglycemic alerts; and (4) mobile application setup and data transmission configuration for patients.

Trial Locations (2)

Unknown

RECRUITING

Qianhu Hospital, Ningbo

RECRUITING

Fuming Street Community Health Service Center, Ningbo

All Listed Sponsors
lead

Peking University

OTHER